ABCL
AbCellera Biologics Inc.$5.53
LiveJun 18, 2026
Market cap
$1.69B
52w range
2.75 – 6.79
P / E
—
EPS
—
Volume
6.76M
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on AbCellera Biologics Inc.’s valuation06-05today
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $7.50 (+35.62%)
Candlestick · 1Y
Open in chart workstation →ABCL
5.26+50.29%H 6.79L 2.75MA50 4.28MA200 —Avg vol 5.1M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.65% | +4.34% | +36.54% | +56.66% | +53.61% | +61.70% | +62.17% | -26.36% | -75.66% | -90.61% | -90.61% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$5.60
Bid
$5.55
16 sh
Ask
$5.70
12 sh
Spread
$0.150
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.51%
- Communication Services+1.85%
- Utilities+1.35%
- Consumer Cyclical+0.30%
- Consumer Defensive-0.30%
- Energy-0.45%
- Industrials-0.48%
- Basic Materials-0.66%
- Financial Services-0.67%
- Real Estate-0.99%
- Healthcare-1.51%
Top industries (issuer's industry highlighted)
- Biotechnology+0.28%
- Oil & Gas Energy+8.53%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Electronic Gaming & Multimedia+5.23%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Grocery Stores-4.35%
- Financial - Mortgages+4.08%
- Broadcasting+4.00%
- Computer Hardware-3.67%
- Internet Content & Information+3.58%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Is ABCELLERA BIOLG (ABCL) Outperforming Other Medical Stocks This Year?zacks.com·Jun 17, 2026
- Jazz Pharma, AbCellera ink antibody deal worth up to $876 millionreuters.com·Jun 17, 2026
- AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cashseekingalpha.com·Jun 17, 2026
- AbCellera: Q3 Hot Flashes Data Drop Aside, This Stock Is A Difficult Sellseekingalpha.com·Jun 09, 2026
- Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a Betzacks.com·Jun 08, 2026
- AbCellera Biologics Inc. (ABCL) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 05, 2026
- AbCellera Appoints Dr. Victor Sandor to its Board of Directorsgurufocus.com·Jun 05, 2026
- AbCellera Appoints Dr. Victor Sandor to its Board of Directorsbusinesswire.com·Jun 05, 2026
Peers
No peer list available for ABCL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|